Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d43c883aa035c2b0560e1968520554fd |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-022 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2008-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ed689373759e7e1d8bede388f072476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e3cc082858493d71fb08e6d1104ed70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b76762697eed91c06dbb6a2d9e6083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64bd242f176f878b0c0d7827ad09be1 |
publicationDate |
2008-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008118471-A1 |
titleOfInvention |
Constitutive gene expression in conjunction with ionizing radiation |
abstract |
The present disclosure demonstrates the successful use of constitutive promoters operatively linked to genes encoding radiosensitizing or radioprotecting factors, administered to cells, tissues, or patients in conjunction with radiation exposure. Also disclosed are pharmacological preparations to be used to increase the levels of radiosensitizing compounds such as TNF-α, or radioprotective compounds such as MnSOD, in specified tissues or tumors of a subject. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009321338-A1 |
priorityDate |
1994-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |